General Information of Drug Transporter (DT)
DT ID	DTD0012 Transporter Info
Gene Name	ABCC3
Protein Name	Multidrug resistance-associated protein 3
Gene ID	8714
UniProt ID	O15438
Genetic Polymorphisms of DT (GPD)
Genetic Polymorphism	rs1051640
Site of GPD	chr17:50691125 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	A>G
Minor Allele Frequency	G=0.1040/521 (Global)
Allele G	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Cisplatin	Drug Info	Neoplasm	Correlated with the increased ototoxicity risk in patients (compare with Allele A); Irrelevant to the ototoxicity risk in patients (compare with allele A)		[ 1], [ 2], [ 3]
Cisplatin	Drug Info	Testicular Neoplasm	Irrelevant to the likelihood of ototoxicity in patients (compare with allele A)		[ 4]
Genetic Polymorphism	rs4148416
Site of GPD	chr17:50676062 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>T
Minor Allele Frequency	T=0.1370/686 (Global)
Allele T	Click to Show/Hide the Full List of Affected Drugs:            5 Drugs in Total
Methotrexate	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with allele C)		[ 5]
Vincristine	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with allele C)		[ 5]
Cisplatin	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with allele C)		[ 5]
Doxorubicin	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with allele C)		[ 5]
Cyclophosphamide	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with allele C)		[ 5]
Genetic Polymorphism	rs4793665
Site of GPD	chr17:50634726 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>A / C>T
Minor Allele Frequency	C=0.3313/1659 (Global)
Genotype CC	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Morphine	Drug Info	Pain	Correlated with the increased drug metabolism in patients (compare with Genotypes CT + TT)		[ 6]
Genetic Polymorphism	rs9895420
Site of GPD	chr17:50634677 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	T>A
Minor Allele Frequency	A=0.1276/639 (Global)
Genotypes AA + AT	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Methotrexate	Drug Info	Precursor Cell Lymphoblastic Leukemia-Lymphoma	Correlated with the decreased likelihood of thrombocytopenia in patients (compare with Genotype TT); Correlated with the increased drug plasma levels in patients (compare with Genotype TT); Correlated with the increased relapse in the central nervous system risk in patients (compare with Genotype TT)		[ 7]
References
1	Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children. Clin Pharmacol Ther. 2013 Aug;94(2):243-51.
2	Genetic markers of cisplatin-induced hearing loss in children. Clin Pharmacol Ther. 2014 Sep;96(3):296-8.
3	Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin. Pharmacogenomics J. 2017 Dec;17(6):515-520.
4	Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer. JAMA Oncol. 2017 Nov 1;3(11):1558-1562.
5	Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study. PLoS One. 2011;6(10):e26091.
6	ABCC3 and OCT1 genotypes influence pharmacokinetics of morphine in children. Pharmacogenomics. 2014 Jul;15(10):1297-309.
7	Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia. Pharmacogenomics J. 2012 Oct;12(5):386-94.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.